Charles R Jonassaint
Overview
Explore the profile of Charles R Jonassaint including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
45
Citations
472
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
OBrien J, Drake J, Bearden D, Ono K, Sil S, Cohen L, et al.
Pain Rep
. 2024 Dec;
10(1):e1189.
PMID: 39664708
Introduction: Accurate assessment of pain severity is important for caring for patients with sickle cell disease (SCD). The Brief Pain Inventory was developed to address limitations of previous pain-rating metrics...
2.
OBrien J, Jonassaint C, Parchuri E, Lalama C, Badawy S, Hamm M, et al.
J Pain
. 2024 Oct;
26:104720.
PMID: 39447944
Painimation, a novel digital pain assessment tool, allows patients to communicate their pain quality, intensity, and location using abstract animations (painimations) and a paintable body image. This study determined the...
3.
OBrien J, McGill L, Burant C, Jonassaint C, Hickman Jr R
J Nurs Meas
. 2024 Oct;
PMID: 39401850
The aim of the study was to examine the psychometric properties of the Sickle Cell Self-efficacy Scale (SCSES) in an anonymous, online cohort of adults with sickle cell disease (SCD)....
4.
Jonassaint C, Lalama C, Carroll C, Badawy S, Hamm M, Stinson J, et al.
Blood Adv
. 2024 Oct;
8(24):6257-6266.
PMID: 39374587
Despite the burden of chronic pain in sickle cell disease (SCD), nonpharmacological approaches remain limited. This multisite, randomized trial compared digital cognitive behavioral therapy (CBT) with a digital pain/SCD education...
5.
Hardy S, Crosby L, Porter J, Sil S, Valrie C, Jonassaint C, et al.
JAMA Netw Open
. 2024 Aug;
7(8):e2429443.
PMID: 39167410
Importance: The introduction of gene therapies into the clinical care landscape for individuals living with sickle cell disease (SCD) represents a momentous achievement with the potential to rewrite the story...
6.
Jonassaint C, Parchuri E, OBrien J, Lalama C, Lin J, Badawy S, et al.
Br J Haematol
. 2024 Jan;
204(3):1029-1038.
PMID: 38171495
Depressive symptoms are prevalent in individuals living with sickle cell disease (SCD) and may exacerbate pain. This study examines whether higher depressive symptoms are associated with pain outcomes, pain catastrophizing,...
7.
Parchuri E, Pacella-LaBarbara M, OBrien J, Gruen D, Guyette F, Brown J, et al.
Trauma Surg Acute Care Open
. 2023 Nov;
8(1):e001200.
PMID: 38020866
Introduction: Sickle cell disease (SCD) is associated with vaso-occlusive events (VOEs) that can lead to disease complications, including early mortality. Given that similar inflammatory responses characterize VOE and traumatic injury,...
8.
Newman T, Yang J, Suh K, Jonassaint C, Kane-Gill S, Novelli E
JAMA Netw Open
. 2023 Nov;
6(11):e2344546.
PMID: 37991760
Importance: Despite hydroxyurea being an established treatment for sickle cell disease (SCD), it remains underused. The recent approval of the disease-modifying treatments (DMTs) l-glutamine, crizanlizumab, and voxelotor underscores the need...
9.
Hoffman B, Sidani J, Jonassaint C, Wolynn R, Donovan A
Cureus
. 2023 Aug;
15(7):e41526.
PMID: 37551225
Introduction Racism is a pervasive social problem that influences medicine, highlighting the need for interventions. One promising educational technique, referred to as edutainment, utilizes clips from television shows as an...
10.
Schweiberger K, Verma R, Faulds S, Jonassaint C, White G, Ray K
Pediatr Res
. 2023 Jan;
94(1):185-192.
PMID: 36690746
Background: The aim of this study was to examine pediatric primary care telemedicine visit scheduling and attendance during the first year of telemedicine. Methods: Using electronic health record data from...